Date: August 27, 2026

Operations Overview

Business Activities: Medical and Healthcare services account for 100% of turnover (NIC Code 8610).

Geographic Presence:

  • 48 locations nationally across 10 Indian states
  • 4 international locations (1 country)
  • 21 Comprehensive Cancer Centres (2 each in Vijayawada, Vadodara, Vishakhapatnam, Jaipur, Ahmedabad, Hubli, and Nashik) in India plus 1 in Kenya
  • 3 multi-specialty hospitals (including Bhavnagar)
  • 6 Day Care Clinics (includes OPDs)
  • 1 PET-CT and 1 Cyclotron facility in Chennai
  • 6 fertility centres under Milann brand (divested June 29, 2026)

Financial Scale:

  • Turnover: ₹25,384.29 million
  • Net Worth: ₹13,319.70 million
  • Paid-up Capital: ₹1,49,30,22,030
  • Export Contribution: 2.13% of total turnover

Customer Base: Serves both insured and uninsured patients, empaneled under CGHS, ECHS, and various state government health programs. Serves patients covered by international social security programs.

Employees & Workforce

Total Workforce: 8,355 employees

  • Permanent employees: 6,759 (50% male, 50% female)
  • Other than permanent: 1,596 (57% male, 43% female)
  • Differently abled employees: 2 (1 male, 1 female)

Turnover Rates (Permanent Employees):

  • FY 2025-26: 25% overall (24% male, 26% female)
  • FY 2024-25: 31% overall (30% male, 31% female)
  • FY 2023-24: 32% overall (31% male, 33% female)

Representation:

  • Board of Directors: 30% female (3 out of 10)
  • Key Management Personnel: 50% female (1 out of 2)

Employee Benefits:

  • 100% coverage for health and accident insurance
  • 50% coverage for maternity benefits (female employees)
  • 50% coverage for paternity benefits (male employees)
  • 50% coverage for day care facilities
  • Cost on wellbeing measures: 0.5% of total revenue
  • Retirement benefits: 100% PF coverage, 100% gratuity coverage, 73% ESI coverage

Training:

  • 96% of employees covered by awareness programs
  • 2,725 training programs conducted covering ethics, patient care, clinical quality, leadership, and environmental sustainability
  • 91% of employees received skill upgradation training

Subsidiaries & Associates

The report covers 23 entities including subsidiaries and associates:

Key Subsidiaries:

  • HCG Medi-Surge Hospitals Private Limited (74% holding)
  • Malnad Hospital & Institute of Oncology Private Limited (70.25% holding)
  • HealthCare Global Senthil Multi Specialty Hospitals Private Limited (100% holding)
  • Vizag Hospital and Cancer Research Centre Pvt Ltd (85% holding after April 13, 2026 acquisition)
  • HealthCare Global (Kenya) Private Limited (100% holding)
  • Cancer Care Kenya Limited (84.89% holding)

Divestment: BACC HealthCare Private Limited (Milann) divested on June 29, 2026

Winding Up: HealthCare Global (Tanzania) Private Limited wound up effective March 02, 2026

Material ESG Issues & Risks

10 Material Issues Identified:

1. Patient Satisfaction and Wellbeing (Opportunity)

2. Medical Quality and Safety (Risk and Opportunity)

3. Energy Management (Risk and Opportunity)

4. Waste Management (Risk)

5. Data Security (Risk and Opportunity)

6. Health and Safety (Risk)

7. Business Ethics and Compliance (Risk and Opportunity)

8. Water Management (Risk)

9. Human Rights (Risk and Opportunity)

10. Sustainable Supply Chain and Responsible Procurement (Risk and Opportunity)

Risk Mitigation Approaches:

  • Implemented rigorous quality protocols and cutting-edge technology for patient safety
  • Solar panel installation to offset 3,300 tons carbon emissions annually
  • Comprehensive Waste Management Manuals with SOPs for different waste types
  • Regular vulnerability assessments and cybersecurity training for data protection
  • Employee Health and Safety Policy with Hazard Identification and Risk Assessment (HIRA)
  • Proactive regulatory communications and ethics training
  • Water meters installed at all discharge sites, advanced recycling technologies
  • Code of Conduct with human rights protection and zero-tolerance discrimination policy
  • Long-term relationships with reliable suppliers requiring ESG self-declarations

Environmental Performance

Energy Consumption (FY 2025-26):

  • Total Energy: 170,621.49 GJ
  • Renewable: 15,416.23 GJ (electricity only)
  • Non-renewable: 155,205.26 GJ (electricity: 147,916.25 GJ, fuel: 7,289.01 GJ)
  • Energy Intensity: 0.0000067215 per rupee of turnover

Water Management (FY 2025-26):

  • Total Withdrawal: 432,986.22 kl
  • Surface Water: 14,866.06 kl
  • Groundwater: 323,047.83 kl
  • Third Party: 529.96 kl
  • Others: 94,542.37 kl
  • Water Discharged: 346,388.97 kl (sent to third parties)
  • Water Intensity: 0.0000170573 per rupee of turnover

GHG Emissions (FY 2025-26):

  • Scope 1: 1,311.97 metric tonnes CO2 equivalent
  • Scope 2: 29,172.37 metric tonnes CO2 equivalent
  • Emission Intensity: 0.00000120091 per rupee of turnover

Air Emissions (FY 2025-26):

  • NOx: 27.75 metric tonnes
  • SOx: 1.83 metric tonnes
  • Particulate Matter: 1.97 metric tonnes
  • Hazardous Air Pollutants: 0 metric tonnes

Waste Management (FY 2025-26):

  • Total Waste Generated: 578.51 metric tonnes
  • Plastic Waste: 6.53 metric tonnes
  • E-waste: 2.96 metric tonnes
  • Bio-medical Waste: 454.92 metric tonnes
  • Other Hazardous: 0.21 metric tonnes
  • Other Non-hazardous: 113.89 metric tonnes
  • Waste Disposal: Incineration (187.47), Landfilling (65.23), Other (325.81)

Governance & Compliance

Grievance Redressal (FY 2025-26):

  • Employee grievances: 8 filed, 1 pending (under enquiry proceedings)
  • Customer grievances: 3 filed, 0 pending
  • Sexual harassment complaints: 8 filed, 1 pending
  • No complaints from communities, investors, shareholders, or value chain partners

Regulatory Compliance:

  • No fines, penalties, or punishment from regulators/law enforcement agencies
  • No disciplinary actions against Directors/KMPs/employees for bribery/corruption
  • No complaints regarding conflict of interest
  • Compliant with all applicable environmental laws

Certifications & Accreditations:

  • ISO 15189 Medical Laboratory Accreditation
  • College of American Pathologists (CAP) Laboratory Accreditation
  • NABL Accreditation
  • NABH Accreditation
  • ISO 27001:2022 Information Security Management System

CSR & Social Initiatives

CSR Applicability: Yes, under Section 135 of Companies Act, 2013

CSR Projects & Beneficiaries:

  • School Infrastructure: 325 beneficiaries (30% vulnerable/marginal groups)
  • School Development: 325 beneficiaries (30% vulnerable/marginal groups)
  • Skill Development: 514 beneficiaries (58% vulnerable/marginal groups)
  • Model Village: 209 beneficiaries (93% vulnerable/marginal groups)
  • Women Leadership: 1,189 beneficiaries (43% vulnerable/marginal groups)
  • Teachers Training: 23 beneficiaries (30% vulnerable/marginal groups)

Data Security Incident

On September 08, 2025, CERT-In notified the company about an online post by an unauthorized third-party regarding marketing data. The company appointed Grant Thornton to conduct a detailed review. Company systems remained operational and unaffected, and the data did not contain personal health, clinical, or healthcare information.